FDA approves Qfitlia to cut bleeding episodes in patients with hemophilia
The U.S. Food and Drug Administration has approved Sanofi's Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce ...
Managed Healthcare Executive1d
Costs of Hemophilia With Inhibitors Are High, Warranting Better Management | AMCP Annual 2025
The FDA has recently approved two new prophylactic treatments for people with hemophilia who develop antibodies to clotting ...
BioSpace6d
Sanofi, Alnylam Win First RNAi Approval for Hemophilia A and B
Unlike other hemophilia therapies, Qfitlia is indicated for both hemophilia A and B, and can be given in patients regardless ...
Medscape8d
Fitusiran Approved for Hemophilia A, B
The US Food and Drug Administration has approved fitusiran for bleeding prophylaxis in hemophilia A and B with or without ...
MPR2d
Qfitlia, a Novel Treatment for Hemophilia A or B, Gets FDA Approval
Fitusiran is a small interference RNA therapeutic designed to prevent bleeds in patients with hemophilia A or B by lowering antithrombin.
Fierce Pharma8d
Sanofi's versatile Qfitlia scores FDA nod to enter crowded hemophilia market
Over the last three years, the FDA has approved six new hemophilia drugs, including three gene therapies. | Over the last ...
FDA Approves Sanofi's Hemophilia Drug
The U.S. Food and Drug Administration on Friday approved Sanofi SA’s (NASDAQ:SNY) Qfitlia (fitusiran), the first antithrombin ...
Medical Dialogues5d
FDA Approves fitusiran for Hemophilia A and B
The FDA has approved fitusiran, now named Qfitlia, for routine prophylaxis in patients aged 12 and older with hemophilia A or ...
Yahoo Finance9d
FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors
Hemophilia A and hemophilia B are genetic bleeding disorders caused by a dysfunction or deficiency of coagulation factor VIII (FVIII) or IX (FIX), respectively. Patients with these hemophilias are ...
U.S. News & World Report4d
FDA Approves Qfitlia to Cut Bleeding Episodes in Patients With Hemophilia
Subcutaneous Qfitlia does not replace the missing coagulation factor VIII or IX ... 177 adult and pediatric male patients with either hemophilia A or hemophilia B. Among participants with ...
MedPage Today9d
Fitusiran Approved for Hemophilia A and B
"Today's approval of Qfitlia is significant for patients with hemophilia because it can ... treatment with bypassing agents (BPAs) or clotting factor concentrates. In the two trials -- ATLAS ...